Merck v. Teva, Commercial Court Antwerp (Rechtbank van Koophandel te Antwerpen), 20 October 2009

The Antwerp Commercial Court dismissed Merck's claim for injunctive relief against Teva, ruling that Teva's montelukast-based generic medicines do not infringe Merck's European patent (EP 0 737 186) with respect to an improved process for preparation of the active ingredient montelukast, either literally or by equivalents.

A full summary of this case has been published on Kluwer IP Law.